Company page
Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc. is a public company traded under the ticker CLDX in the American market. The company has a market capitalization of approximately $2.55 billion. Celldex focuses on developing innovative therapies for cancer and other serious diseases.
- Ticker
- CLDX:NASDAQ
- Asset type
- Stock
- Market cap
- $2.55B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD